Literature DB >> 33560463

[Antibiotic prophylaxis for endourological interventions considering antibiotic stewardship].

Jennifer Kranz1,2, Laila Schneidewind3, Adrian Pilatz4, Flo Ri An Wagenlehner4.   

Abstract

Perioperative antibiotic prophylaxis in endourology is used to reduce or avoid postoperative surgical site infections and complicated urinary tract infections. Special attention is paid to antibiotic stewardship strategies to avoid the continuing selection of antibiotics and multidrug-resistant uropathogens as well as collateral damage to the microbiome. The individual risk profile, the local resistance situation, the expected pathogen spectrum, the pharmacokinetics and the approval of each substance are important aspects to be considered in the indications and selection of perioperative antibiotic prophylaxis. Furthermore, applicable hygiene regulations and the surgical care of an intervention must be observed.

Entities:  

Keywords:  Endourology; Pharmacokinetics; Tissue infections; Urinary tract infections; Uropathogens

Mesh:

Substances:

Year:  2021        PMID: 33560463     DOI: 10.1007/s00120-021-01455-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  16 in total

1.  [Antibiotic prophylaxis in urology].

Authors:  F M E Wagenlehner; M Grabe; K G Naber; T E Bjerklund Johansen; C K Naber; W Weidner
Journal:  Urologe A       Date:  2011-11       Impact factor: 0.639

Review 2.  [Prudent use of antimicrobial prophylaxis : Prevention of increasing antibiotic resistance].

Authors:  C Hein; A Pilatz; F M E Wagenlehner
Journal:  Urologe A       Date:  2017-09       Impact factor: 0.639

Review 3.  Antibiotic prophylaxis in urologic procedures: a systematic review.

Authors:  A M Jikke Bootsma; M Pilar Laguna Pes; Suzanne E Geerlings; Astrid Goossens
Journal:  Eur Urol       Date:  2008-03-24       Impact factor: 20.096

4.  Time to Adapt Our Practice? The European Commission Has Restricted the Use of Fluoroquinolones since March 2019.

Authors:  Gernot Bonkat; Adrian Pilatz; Florian Wagenlehner
Journal:  Eur Urol       Date:  2019-06-23       Impact factor: 20.096

5.  Antibiotic Prophylaxis for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-Analysis.

Authors:  Adrian Pilatz; Konstantinos Dimitropoulos; Rajan Veeratterapillay; Yuhong Yuan; Muhammad Imran Omar; Steven MacLennan; Tommaso Cai; Franck Bruyère; Ricardo Bartoletti; Bela Köves; Florian Wagenlehner; Gernot Bonkat; Benjamin Pradere
Journal:  J Urol       Date:  2020-02-27       Impact factor: 7.450

6.  An Update of the American Urological Association White Paper on the Prevention and Treatment of the More Common Complications Related to Prostate Biopsy.

Authors:  Michael A Liss; Behfar Ehdaie; Stacy Loeb; Maxwell V Meng; Jay D Raman; Vanessa Spears; Sean P Stroup
Journal:  J Urol       Date:  2017-03-29       Impact factor: 7.450

Review 7.  Preoperative assessment of the patient and risk factors for infectious complications and tentative classification of surgical field contamination of urological procedures.

Authors:  Magnus Grabe; Henry Botto; Mete Cek; Peter Tenke; Florian M E Wagenlehner; Kurt G Naber; Truls E Bjerklund Johansen
Journal:  World J Urol       Date:  2011-07-22       Impact factor: 4.226

Review 8.  Prophylactic antibiotics to reduce the risk of urinary tract infections after urodynamic studies.

Authors:  Richard Foon; Philip Toozs-Hobson; Pallavi Latthe
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

9.  Nonantibiotic Strategies for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-Analysis.

Authors:  Benjamin Pradere; Rajan Veeratterapillay; Konstantinos Dimitropoulos; Yuhong Yuan; Muhammad Imran Omar; Steven MacLennan; Tommaso Cai; Franck Bruyère; Riccardo Bartoletti; Bela Köves; Florian Wagenlehner; Gernot Bonkat; Adrian Pilatz
Journal:  J Urol       Date:  2020-10-07       Impact factor: 7.450

Review 10.  [Infectious complications following prostate biopsy-Major changes 2020].

Authors:  A Pilatz; G Bonkat; F Wagenlehner
Journal:  Urologe A       Date:  2020-12       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.